ChoA Pharmaceutical Announces 5-to-1 Reverse Stock Split to Reduce Outstanding Shares by 80% for Price Stability
ChoA Pharmaceutical has called an extraordinary general meeting of shareholders on July 6, 2026, to propose a share consolidation.
The reverse stock split will merge 5 common shares into 1 share, raising the par value from 500 won to 2,500 won, reducing outstanding shares from 30,979,827 to 6,195,965.
The stated goal of the consolidation is to stabilize the stock price and enhance corporate value by maintaining an appropriate number of outstanding shares, which is a structural adjustment without change in capital.
This action does not involve new capital raising or changes in dividend policy, and existing shareholders' equity stake remains unchanged.
[AI Summary]ChoA Pharmaceutical's reverse stock split is a capital restructuring that reduces the number of shares by 80% to support the share price but provides no direct increase in intrinsic shareholder value, and future price movement will depend on market reception.